BANK OF AMERICA CORP /DE/ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 13 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$1,152,000
+1239.5%
1,965,000
+2211.8%
0.00%
Q1 2022$86,000
+19.4%
85,000
+30.8%
0.00%
Q4 2021$72,000
-96.9%
65,000
-96.5%
0.00%
Q3 2021$2,341,0001,870,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders